Finally, DNA damage-induced NF-κB activation appeared to be PKC-independent in cervical cancer cells, pointing to a novel upstream mechanism activating the C3BM complex and NF-κB signaling in response to DNA damage. This evidence concerns the gene NFKB1 and cervical carcinoma.